The Importance Of Bcma Targeting

Hans Lee, MD, University of Texas MD Anderson Cancer Center, Houston, TX, discusses the important

Hans Lee, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, provides an overview of the use of ...

In this video, Hans Lee, MD, University of Texas MD Anderson Cancer Center, Houston, TX, discusses

Karthik Ramasamy, MBBS, MRCP, FRCPath, PhD, Oxford University Hospitals NHS Foundation Trust, Oxford, UK, shares some ...

Nikhil Munshi, MD, MBBS, Dana-Farber Cancer Institute, Boston, MA, outlines the use of the B-cell maturation antigen (

... not be sufficient to achieve long-term disease control or a cure

Sagar Lonial, Winship Cancer Institute of Emory University, Atlanta, GA, discusses the promising results of anti-

In this video, Hans Lee, MD, University of Texas MD Anderson Cancer Center, Houston, TX, discusses the use of

Speaking from the American Society of Oncology (ASCO) 2018 Annual Meeting, held in Chicago, IL, Stephan Grupp, MD, PhD, ...

Sagar Lonial, MD, FACP, takes an in-depth look at current anti-

Niels van de Donk, MD, PhD, of VU University Medical Center, Amsterdam, Netherlands, talks on the sequencing of B-cell ...

Rakesh Popat, BSc, MBBS, MRCP, FRCPath, PhD, of the University College London Hospitals, London, UK, highlights B-cell ...

Paola Neri, MD, PhD, University of Calgary, Calgary, AB, Canada, highlights promising

Shifting toward the future of

Andrew Yee, MD, of Massachusetts General Hospital Cancer Center, Boston, MA, discusses the KarMMa-2 trial (NCT03601078) ...

Amrita Krishnan, MD, City of Hope, Duarte, CA, briefly comments on how

IMF Chief Medical Officer Joseph Mikhael, MD, discusses

Watch the full course and our most up-to-date content here: https://linktr.ee/HealthTreeUniversity Create a free account to track ...

Hans Lee, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, explores strategies to improve outcomes ...

Surbhi Sidana, MD, Stanford University, Stanford, CA, discusses the sequencing of